Nursing practice questions with comprehensive rationales
NurseDive Free Nursing Practice Question
The nurse reinforces instructions regarding when to take levothyroxine and determines teaching was effective when the client states the medication should be taken in which manner?
A. 30 to 60 minutes before breakfast
Levothyroxine is usually recommended to be taken 30 to 60 minutes before breakfast to enhance absorption, but this is not the answer indicated by the client's statement.
B. At bedtime
Taking levothyroxine at bedtime is another acceptable option and may be more convenient for some individuals. Both options (morning or bedtime) are valid.
C. When they feel fatigued
Taking levothyroxine when feeling fatigued is not a specific guideline for medication administration.
D. With an antacid
Taking levothyroxine with an antacid may interfere with absorption and is not recommended.
This question is an excerpt from Nurse Dive's nursing test bank - Ramsussen Section 4 Module 11. Pharmocology For Professional Nursing Proctored Exam. Take the full exam now
Full Explanation
a) Levothyroxine is usually recommended to be taken 30 to 60 minutes before breakfast to enhance absorption, but this is not the answer indicated by the client's statement.
b) Taking levothyroxine at bedtime is another acceptable option and may be more convenient for some individuals. Both options (morning or bedtime) are valid.
c) Taking levothyroxine when feeling fatigued is not a specific guideline for medication administration.
d) Taking levothyroxine with an antacid may interfere with absorption and is not recommended.
Similar Questions
The nurse is providing client education for a postmenopausal client; which risks associated with estrogen/progestin therapy should the nurse discuss with the client? (Select all that apply.)
A. Decreased bone density
This is not a risk of estrogen/progestin therapy. In fact, estrogen/progestin therapy can help prevent osteoporosis and fractures by increasing bone density and strength.
B. Ovarian cancer
This is a possible risk of estrogen/progestin therapy. Some studies have suggested that taking estrogen/progestin therapy for more than five years may increase the risk of ovarian cancer. However, other studies have not found this association
C. Stroke
This is a serious risk of estrogen/progestin therapy. Estrogen/progestin therapy can increase the risk of blood clots, which can lead to stroke or heart attack. The risk is higher for women who smoke, have high blood pressure, diabetes, or a history of cardiovascular disease.
D. Increased colon cancer
This is not a risk of estrogen/progestin therapy. In fact, some studies have suggested that estrogen/progestin therapy may reduce the risk of colon cancer by lowering inflammation and promoting regular bowel movements.
E. Deep vein thrombosis
This is another serious risk of estrogen/progestin therapy. Deep vein thrombosis (DVT) is a condition where a blood clot forms in a deep vein, usually in the leg. It can cause pain, swelling, and redness in the affected area. If the clot breaks off and travels to the lungs, it can cause a life threatening condition called pulmonary embolism (PE). Estrogen/progestin therapy can increase the risk of DVT and PE by making the blood more likely to clot
Full Explanation
A) This is not a risk of estrogen/progestin therapy. In fact, estrogen/progestin therapy can help prevent osteoporosis and fractures by increasing bone density and strength.
B) This is a possible risk of estrogen/progestin therapy. Some studies have suggested that taking estrogen/progestin therapy for more than five years may increase the risk of ovarian cancer. However, other studies have not found this association
C) This is a serious risk of estrogen/progestin therapy. Estrogen/progestin therapy can increase the risk of blood clots, which can lead to stroke or heart attack. The risk is higher for women who smoke, have high blood pressure, diabetes, or a history of cardiovascular disease.
D) This is not a risk of estrogen/progestin therapy. In fact, some studies have suggested that estrogen/progestin therapy may reduce the risk of colon cancer by lowering inflammation and promoting regular bowel movements.
E) This is another serious risk of estrogen/progestin therapy. Deep vein thrombosis (DVT) is a condition where a blood clot forms in a deep vein, usually in the leg. It can cause pain, swelling, and redness in the affected area. If the clot breaks off and travels to the lungs, it can cause a life threatening condition called pulmonary embolism (PE). Estrogen/progestin therapy can increase the risk of DVT and PE by making the blood more likely to clot
Which statement by a client indicates an understanding of self-care precautions when taking warfarin?
A. "My warfarin dose may need to be readjusted when I take a course of antibiotics."
Antibiotics can interact with warfarin, potentially affecting the INR, so dose adjustments may be necessary.
B. "I should expect pink urine due to metabolic bi-products of the dye used in this medication."
Pink urine is not an expected side effect of warfarin; this statement is inaccurate.
C. "I should eat spinach to increase my iron count if my INR goes below two."
Eating spinach to increase iron count is not a relevant action related to warfarin or INR levels.
D. "Herbal remedies are fine, but I shouldn't take aspirin without consulting my provider."
Warfarin interacts with many substances, including herbal remedies and aspirin. Notifying the provider before taking new medications or supplements is crucial for proper management.
Full Explanation
A) Antibiotics can interact with warfarin, potentially affecting the INR, so dose adjustments may be necessary.
B) Pink urine is not an expected side effect of warfarin; this statement is inaccurate.
C) Eating spinach to increase iron count is not a relevant action related to warfarin or INR levels.
D) Warfarin interacts with many substances, including herbal remedies and aspirin. Notifying the provider before taking new medications or supplements is crucial for proper management.
A client who is suffering from an acute gout attack wants to know how colchicine differs from probenecid and allopurinol in its actions. Which of these statements shows the need for further teaching regarding the purpose and use of these medications?
A. Allopurinol prevents the synthesis of uric acid.
Allopurinol inhibits the synthesis of uric acid, preventing its formation.
B. All of these medications should be taken concurrently during an acute attack, and non-steroidal anti-inflammatory drugs (NSAIDs) should be added for pain control.
Colchicine is typically used for gout flares and reduces inflammation but is not usually taken concurrently with probenecid and allopurinol. NSAIDs or corticosteroids are often used for pain control during acute attacks.
C. Colchicine reduces inflammation caused by uric acid.
Colchicine is known for its anti-inflammatory properties but does not prevent uric acid synthesis or facilitate its elimination.
D. Probenecid facilitates the elimination of uric acid in the nephrons.
Probenecid increases the excretion of uric acid in the urine.
Full Explanation
A) Allopurinol inhibits the synthesis of uric acid, preventing its formation.
B) Colchicine is typically used for gout flares and reduces inflammation but is not usually taken concurrently with probenecid and allopurinol. NSAIDs or corticosteroids are often used for pain control during acute attacks.
C) Colchicine is known for its anti-inflammatory properties but does not prevent uric acid synthesis or facilitate its elimination.
D) Probenecid increases the excretion of uric acid in the urine.